Yanming Wang

Chairman of Board/Founder  

Dr. Yanming Wang is a Key Opinion Leader in the field. As a biochemist by training, Dr. Wang has been working on the target for nearly 20 years. He firstly discovered the function of the target in citrullination and later on, his studies expand to functional studies in cellular and rodent models, which leads to the development of a tool inhibitor. Up to now, Dr. Wang has published more than 20 scientific papers on this target alone (cited over 15000 times).

Yan Xia

VP, MedChem

Dr. Yan Xia has worked more than 30 years in the pharmaceutical industry, including 28 years in Schering-Plough. After graduating from the department of Chemistry, Nankai University, Dr. Yan Xia, received a World Bank scholarship and went to the University of Pittsburgh to pursue a doctorate degree in organic synthesis. Dr. Yan Xia participated in the research and development of more than 10 drugs in the area of cardiovascular disease, diabetes, central nervous system and hepatitis, and won the Edison Invention Award twice. Dr. Xia has published more than 70 academic papers and patents.

Gong Chen

Board Member/Co-Founder

Dr. Gong Chen has been working in the department of Chemistry of Penn State University since 2008Since March 2015, he has been working the State Key Laboratory of Organic Chemistry in Nankai university. Dr. Chen has published more than 50 papers and has 1 granted patent, He has won many awards for the excellence in research including the award for US - NSF CAREER, Thieme Chemistry Journal Award, Amgen Young Investigator Award.